The Bacillus thuringiensis group of aerobic, spore-forming soil bacteria has been used for the biological control of insect pests for several decades. The ␦-endotoxins, which are insecticidal crystal proteins are produced by this species during the sporulation phase of growth. On the bases of target insect specificity and DNA homology, the ␦-endotoxins have been classified into at least five (CryI to CryV) major classes (11, 26) . The CryI-type ␦-endotoxins are active against the larvae of lepidopteran insects (11) . Upon ingestion, the CryI-type ␦-endotoxins are solubilized by the alkaline conditions existing in the midgut of susceptible larvae and release a protoxin (130 to 135 kDa). The protoxin is further processed into a proteaseresistant active toxin (60 to 65 kDa) by the insect gut proteases (12) . This activated toxin is proposed to bind to a specific receptor(s) located in the luminal plasma membrane of midgut columnar epithelial cells, irreversibly integrates to the membrane, and initiates formation of pores or ion channels (selective or nonselective) (4, 10, 25) .
A three-domain structure for a related coleopteran-active ␦-endotoxin, CryIIIA, has been determined by X-ray crystallography (18) . Domain I, a seven-␣-helix bundle comprising the N-terminal 250 amino acids, is proposed to participate in ion channel formation. Domain II, consisting of three sets of ␤-sheets, each terminating with a loop, is presumed to be involved in membrane binding. Domain III, a ␤-sandwich which includes the conserved C-terminal region of the toxin, is now believed to play a role in ion channel function (2) . Li et al. (18) have suggested a similar structure for other insecticidal ␦-endotoxins, since the core of the molecule encompassing all the domain interfaces is built on five highly conserved blocks of amino acids common among most of the ␦-endotoxins.
Several in vitro membrane binding studies have been performed with brush border membrane vesicles (BBMV) isolated from susceptible insect larval midguts (10, 13, 17, 19, 28) . Often there is a positive correlation between either binding affinity or number of binding sites and insect toxicity (17, 28) . However, there are certain exceptions to the above generalization (4, 30) . There is often more than one specific toxin binding site on the BBMV for certain toxins (21, 28) . The toxin-binding proteins (receptors) of several insects have been identified by the ligand blotting method (4, 21, 27) . More recently, Knight et al. (14) and Sangadala et al. (23) have identified and purified a CryIAc toxin-binding protein from Manduca sexta BBMV. This membrane receptor is aminopeptidase-N, which is a GalNAc-bearing glycoprotein (15) .
The insect specificity-determining regions of several toxins have been identified by exchanging short peptide segments between different toxins (5, 6) . In an early study, Ge et al. (6) transferred the Bombyx mori activity from a highly active toxin (CryIAa) to a relatively inactive toxin (CryIAc) by exchanging the amino acids 332 to 450. Later, a direct correlation between toxicity and the membrane binding properties of those mutants with B. mori BBMV was established (17) . The initial (reversible) binding of CryIAa toxin to B. mori BBMV was also disrupted by the deletion of residues 365 to 371 of CryIAa toxin (19) .
In this work we evaluate the function of the putative loop residues, 370 PFNIGI 375 , of domain II, loop 2 of B. thuringiensis ␦-endotoxin CryIAb with M. sexta larvae. We demonstrate that deletion of amino acids 370 to 375 (D2) and alanine substitution of residue F-371 (F371A) and G374A significantly affect larvicidal potency for M. sexta. We also compare the BBMV binding and short-circuit current (Isc) inhibition properties of the wild-type and mutant toxins to M. sexta. The irreversible association of BBMV (receptor)-bound CryIAb toxin to M. sexta is significantly reduced when residues F-371 and G-374 are replaced with alanine. Our results suggest that in addition to initial receptor binding, irreversible integration of the ␦-endotoxin into the midgut epithelial cells is a critical step for toxicity and is affected by mutations in domain II, loop 2.
MATERIALS AND METHODS
Site-directed mutagenesis. The cryIAb(pSB033) gene was provided by Sandoz Agro Inc., Palo Alto, Calif. pSB033 is the cryIAb gene cloned from HD133 into pBluescript KSϩ with the cryIAc terminator and cryIC promoter (constructed by Sandoz Agro Inc.). Mutations in cryIAb were performed with the template pSB033b. This was constructed by recloning the ApaI-to-NotI fragment (4.073 kb) of pSB033 into the corresponding enzyme-treated pBluescript KSϪ vector. Uracil-containing template was obtained by transforming Escherichia coli CJ236 (Bio-Rad) with pSB033b. Oligonucleotides used for this work were provided by Sandoz Agro Inc. The site-directed mutagenesis procedure (Muta-Gene M13 in vitro mutagenesis kit; Bio-Rad) was as detailed in the manufacturer's manual. Single-stranded DNA sequencing was carried out by the method of Sanger et al. (24) by following the manufacturer's (United States Biochemical) instructions. All restriction enzymes were purchased from Boehringer Mannheim Biochemicals.
Purification, solubilization, and activation of ␦-endotoxin inclusions. Wildtype and mutant proteins were expressed in E. coli MV1190, and the ␦-endotoxins were purified as previously described (17) . The final pellet, referred to as the crystal protein, was solubilized in crystal solubilization buffer (50 mM Na 2 CO 3 NaHCO 3 , pH 9.5, 10 mM dithiothreitol) at 37ЊC for 2 h. The yield of solubilized protein was estimated by the Coomassie protein assay reagent (Pierce Chemical Co.). The solubilized protoxin was digested with 2% (by mass) trypsin at 37ЊC for 5 h and analyzed by sodium dodecyl sulfate (SDS)-10% polyacrylamide gel electrophoresis (PAGE).
Iodination of ␦-endotoxins. Iodination of trypsin-activated toxin was carried out with iodobeads by following the manufacturer's (Pierce) instructions. One iodobead was incubated with 1.0 mCi of Na 125 I (diluted in 50 l of sodium carbonate buffer) at room temperature for 5 min. A total of 25 g of toxin solution was then added to the reaction tube, and the incubation was continued for another 10 min at room temperature. The iodination reaction was stopped by removing the reaction solution from the iodobead. Iodinated proteins were separated from free iodine by passing the sample through a 2.0-ml Excellulose column (Pierce Chemical Co.) according to the instructions provided by the manufacturer. The specific activities of the labeled CryIAb, D2, F371A, N372A, G374A, and I375A proteins were 1.5, 1.1, 1.5, 1.4, 1.3, and 1.4 mCi/mg, respectively.
Midgut isolation and BBMV purification. M. sexta eggs were kindly supplied by Michael Jackson, U.S. Department of Agriculture (North Carolina). The eggs were hatched and raised to the fifth instar on artificial diet (Bio Serve). The dissection procedure was as described previously (2) . BBMV were prepared by the differential magnesium precipitation method as modified by Wolfersberger et al. (33) . The final BBMV pellet was resuspended in binding buffer (8 mM NaHPO 4 , 2 mM KH 2 PO 4 , 150 mM NaCl, pH 7.4), and the protein concentration was measured with the Coomassie protein assay reagent (Pierce).
Competition binding assay. A total of 100 g of BBMV per ml was incubated with 1 nM 125 I-labeled toxin in the presence of increasing concentrations (0 to 1,000 nM) of the appropriate nonlabeled toxin in 100 l of binding buffer (with 0.1% bovine serum albumin) at room temperature for 1 h. The unbound toxin was separated from the BBMV-bound toxin by centrifugation at 13,500 ϫ g for 15 min in a Fisher Microfuge. The pellet which contained the bound toxin was washed three times with binding buffer, and the radioactivity in the final pellet was measured in a gamma counter (Beckman). Binding data were analyzed by using the LIGAND computer program (20) . In homologous competition assays, one labeled protein was inhibited by the same nonlabeled protein, whereas in heterologous competition assays, labeled CryIAb was inhibited by nonlabeled mutant toxins.
Dissociation binding assay. 125 I-labeled toxin (1.0 nM) was incubated with 100 g of BBMV per ml in 100 l of binding buffer at room temperature for 2 h (association binding) to achieve saturation binding. In one experiment, 100 nM (final concentration) nonlabeled toxin (in a 10-l volume) was added to each sample tube at 2 h of association reaction, and the reaction was stopped at different time points (10 min to 2 h) by centrifugation. In another experiment, at 2 h of association binding, increasing concentrations (1 to 500 nM) of the corresponding nonlabeled toxin were added and incubation was continued for another 2 h. The samples were centrifuged, pellets were washed three times with binding buffer, and the radioactivity in the final pellet was measured as mentioned before. The counts at 2 h of association reaction were considered to be 100% binding.
Western blotting (immunoblotting).
Gut enzyme digestion of the crystal protein was performed by incubating the protoxin with freshly prepared M. sexta gut enzymes (the gut fluid vomited by the insect upon very gentle squeezing) in 50 mM sodium carbonate buffer (pH 9.5) at 37ЊC for 3 h. The enzyme reaction was stopped by adding Laemmli sample buffer (16) and heating, resolved by SDS-PAGE, and transferred to a polyvinylidene difluoride membrane with a Bio-Rad Trans Blot apparatus. The blot was processed and developed as described by Lu et al. (19) . Anti-CryIAb serum (1:2,000 dilution), raised in a rabbit, was used as the primary antiserum in this experiment.
Ligand blot. A total of 50 g of BBMV proteins was solubilized in Laemmli sample buffer (16) , separated by SDS-7.5% PAGE, and transferred to a polyvinylidene difluoride membrane as described before (19) . The blot was blocked with 3% nonfat dry milk (Kroger Co.) in TTBS (50 mM Tris-HCl, 150 mM NaCl, 0.05% Tween 20) for 1 h, washed three times with TTBS, and incubated with 2 ϫ 10 6 cpm of 125 I-labeled toxin for 1 h at room temperature. The unbound toxin was washed with TTBS (three times, 5 min each time), and the blot was dried and exposed to Fuji RX film for 2 to 3 days.
Insect bioassay. Toxicity assays were performed with newly hatched larvae. A total of 100 l of toxin dilutions (diluted in phosphate-buffered saline [8 mM Na 2 HPO 4 , 2 mM KH 2 PO 4 , 150 mM NaCl, pH 7.4]) was layered on artificial diet (2 cm 2 ) and air dried. A total of 10 to 15 larvae were placed on each dilution, and four to five dilutions were used to determine the slope. Mortality was scored after 5 days. Effective dose estimates (50% lethal concentration of toxin [LC 50 ] and 95% fiducial limits) were obtained by probit analysis (22) .
Voltage clamp analysis. Voltage clamp analysis was performed as described by Chen et al. (2) . The dissection of insects and mounting of midgut membrane were as described by Harvey et al. (8) After 15 min of stabilization, 50 ng of trypsin-activated toxin per ml was injected into the lumen side of the chamber. The volume of the lumen chamber is 3.75 ml. The Isc was tracked with a Kipp and Zonen recorder, and data were collected with the MacLab data acquisition system. The slope of falling Isc was measured.
RESULTS

Construction of mutants.
Mutants with deletions or alanine substitutions at the predicted loop 2 region of domain II of CryIAb toxin were constructed. An amino acid alignment of CryIAb loop 2 residues with CryIIIA is shown in Fig. 1A . This alignment agrees with that of Hodgman and Ellar (9) . The positions of amino acid residues deleted or replaced in CryIAb toxin are shown in Fig. 1B .
Analysis and activation of crystal proteins. Crystal proteins purified from the wild type and mutants were solubilized, activated by trypsin, and analyzed by SDS-PAGE. Our results ( Fig. 2A) showed that the mutants produced protoxins (135 kDa) and trypsin-activated toxins (65 kDa) similar to those of the wild-type CryIAb, except in the case of I373A. Since the mutant I373A did not yield toxin (data not shown), it was not considered for further studies. To evaluate whether the mutations caused any structural alterations to the mutant protein, the protoxins were subjected to M. sexta gut juice. The Western blot analysis showed that the mutants yielded stable 60-kDa toxins similar to those of the wild type (Fig. 2B) . Biological activity. The biological activities of the mutant and wild-type proteins on first-instar M. sexta larvae were compared and are reported in , respectively). Competition membrane binding study. In homologous competition binding assays, labeled toxins were put into competition with the corresponding nonlabeled toxin to evaluate the binding affinity and binding site concentrations on M. sexta BBMV. Our studies showed that the wild-type and mutant proteins were able to bind to M. sexta BBMV with similar binding affinities and binding site concentrations (Fig. 3A and Table 1 ). The binding affinities (K d ) estimated for the toxins were between 0.4 and 1.2 nM (Table 1) . Heterologous competition experiments were performed to evaluate whether the mutant proteins recognize the same binding site as that of the wild-type toxin. When labeled CryIAb toxin was put into competition with nonlabeled mutant proteins, all the mutants competed as efficiently for the CryIAb binding site(s) as did nonlabeled CryIAb (Fig. 3B) .
Dissociation of membrane-bound toxins. Since all the toxins showed similar binding affinities to M. sexta BBMV, we tested the stability of the BBMV-bound toxins. The toxins were first allowed to bind to the BBMV and were then chased with the corresponding nonlabeled toxins. Our results showed that 75 to 80% of the BBMV-bound wild-type toxin and mutant toxins N372A and I375A were not displaced by the addition of nonlabeled ligands (i.e., they were irreversibly associated). In contrast, only 45 to 60% of the mutant toxins D2, F371A, and G374A was able to associate irreversibly with BBMV (Fig.  4A) . The continued decrease in binding for the defective mutants (Fig. 4A) was not due to toxin breakdown or release of labeled fragments, since we could recover the intact labeled toxins after incubation with BBMV for 4 h (data not shown). When the extent of dissociation was analyzed as a function of increasing concentrations of nonlabeled toxin, the maximum dissociation occurred at 100 nM nonlabeled ligand. Also, in agreement with the previous experiment, 75 to 80% of the wild type, N372A, and I375A and 45 to 50% of D2, F371A, and G374A remained associated with the BBMV (Fig. 4B ) after incubation with nonlabeled ligand.
Identification of the toxin-binding polypeptide. To determine the toxin-binding receptor molecule(s), M. sexta BBMV proteins were separated by SDS-7.5% PAGE and transferred to a polyvinylidene difluoride membrane. The membrane was then probed with iodine-labeled CryIAb, D2, F371A, and N372A toxins. Our results showed that all the toxins bound preferentially to a 210-kDa major peptide and to some extent to a diffuse 120-kDa peptide (Fig. 5A) . A similar result was observed when the BBMV proteins were probed with biotin- I-labeled CryIAb toxin to 210-and 120-kDa peptides was inhibited nearly completely when incubated with an excess (250-fold) amount of nonlabeled CryIAb protein (Fig. 5B) .
Voltage clamping study. We examined the inhibition of Isc in response to the addition of wild-type and mutant toxin (50 ng/ml) to the lumen side of the midgut. Isc measures the active transport of ions from the hemolymph side of the midgut membrane to the lumen side. The slopes of Isc inhibition of mutants N372A and I375A were comparable to that for the wild type, whereas the slopes of inhibition of Isc for the mutants D2, F371A, and G374A were six to seven times less than that for the wild type ( Fig. 6 ; Table 1 ).
DISCUSSION
We have previously reported (19) that the amino acid residues 365 to 371 (predicted loop 2) of CryIAa toxin are essential for membrane binding and toxicity to B. mori. In that case, we observed that deletion of or alanine substitution at residues 365 to 371 of domain II significantly affected initial binding as measured by competition binding assays. In this study we have continued our investigation on the predicted receptor binding domain (domain II) of another toxin, CryIAb, and analyzed the function of putative loop 2 amino acid residues (370 to 375), PFNIGI, with M. sexta. We have made the unexpected observation that deletion or modification of some residues in loop 2 of domain II greatly affects the irreversible binding as measured by dissociation assays, although the initial binding as measured by competition binding experiments is not affected.
Insect specificity of several lepidopteran-active CryIA type ␦-endotoxins is often correlated with the hypervariable region between amino acid residues 280 and 550 (5, 6, 29) . The structural alignment of CryIA toxins with the secondary structure of CryIIIA beetle-active toxin, determined by X-ray crystallography, showed that the hypervariable region corresponds to domain II (18) of CryIIIA. Domain II (amino acid residues 291 to 500), composed of three ␤-pleated sheets, each ending in a loop structure, is proposed to participate in receptor binding and host specificity (18) . Although CryIIIA and CryIA share only 33% amino acid identity (9), Yamamoto and Powell (34) have proposed a very strong similarity of domains II and III of CryIIIA toxin to CryIA-type toxins on the basis of computerpredicted secondary structure analysis. These studies allowed us to align the loop 2 residues of CryIIIA and CryIAb (Fig. 1) . This is in agreement with the alignment of Hodgman and Ellar (9) . Using site-directed mutagenesis techniques, we have deleted residues 370 to 375 (D2) and individually replaced residues 371 FNIGI 375 with alanine. Alanine substitutions were chosen because they might not cause gross structural perturbation in the folding of the mutant proteins (3).
All the mutants, except I373A, express ␦-endotoxin at a level comparable to that of the wild-type CryIAb toxin. Our bioassay data show that the mutants D2, F371A, and G374A have substantially lost the larvicidal activity (more than 400-fold) for M. sexta larvae (Table 1) . Three lines of evidence suggest that the loss of larvicidal activity is not a result of the protein being grossly affected or misfolded. First, these proteins can be expressed at levels comparable to those for wild-type CryIAb (Fig. 2A) . Poor expression can be correlated with an unstable or misfolded protein (1). Second, both mutant and wild-type protoxins yielded a 65-kDa fragment after trypsin activation ( Fig. 2A) . Finally, the wild-type and mutant protoxins are similarly processed into a stable 60-kDa toxin on treatment with M. sexta gut juice enzymes (Fig. 2B) .
Our radiolabeled-toxin binding assay data showed that the binding of mutant proteins to M. sexta BBMV is highly specific and saturable, like that of the wild-type toxin (data not shown). Homologous competition binding studies suggested that the binding affinity (K d ) and binding site concentrations (B max ) of both toxic and less-toxic mutants and the wild-type toxin to M. sexta BBMV do not differ significantly ( Fig. 3A; Table 1 ). The heterologous competition experiments, performed to investigate whether the mutant and wild-type toxins recognize the same binding site, reveal that all the mutants successfully compete with the wild-type toxin for the binding to M. sexta vesicles (Fig. 3B ). These data show that the reduced larvicidal activity of D2, F371A, and G374A is not caused by changes in the membrane binding property. Since the deletion of residues 370 to 375 (D2) does not alter the initial binding, it suggests a possible involvement of other segments of domain II, such as loops 1 and 3, in initial receptor binding function. In contrast, the deletion of loop 2 residues 365 to 371 of CryIAa toxin removed all toxicity and considerably reduced the binding to B. mori BBMV (19) . This comparison illustrates the complexity of interaction between different toxins and different insect midgut receptors. Our ligand blot experiments provided additional evidence that the wild-type and mutant (toxic and less-toxic) toxins recognize a common 210-kDa peptide (Fig. 5A) , as previously observed by Vadlamudi et al. (27) . We have also noticed binding to a 120-kDa protein in most of our preparations ( Fig. 5A  and B) . The binding of the labeled CryIAb toxin to 210-and 120-kDa peptides is specific and could be inhibited in the presence of excess nonlabeled CryIAb toxin (Fig. 5B) . These experiments suggested that the mutants D2, F371A, and N372A bind to the same receptor proteins with affinities similar to that of CryIAb, although they have lost most of their toxicity for M. sexta.
Recently, several reports have indicated that the initial binding is not the only factor to determine toxicity. The CryIAc toxin binds with high affinity to Spodoptera frugiperda BBMV but is not toxic to the larvae (4). In another case, Wolfersberger (30) has observed an inverse correlation between membrane binding and toxicity to Lymantria dispar for the toxins CryIAb and CryIAc. In addition, insect toxin resistance is not caused by reduced toxin binding in some cases (7) . These experiments suggest that the late binding events, such as irreversible membrane association of the toxin, could also play a major role in determining the toxicity. Ihara et al. (13) have identified irreversible and reversible components of receptorbound CryIAa and CryIAb toxins with B. mori. They have concluded that CryIAa has a greater irreversible component with B. mori BBMV than does CryIAb, and hence CryIAa is more toxic to the insect.
Interestingly, our dissociation experiments showed a striking difference between toxic and less-toxic mutants. About 75 to 80% of wild-type toxins and toxic mutants are irreversibly associated with the BBMV, whereas only 45 to 50% of the nontoxic mutants is irreversibly associated with the BBMV under similar conditions (Fig. 4) . This considerable reduction in the integration of the receptor-bound toxin could account for the 400-fold difference in toxicity. It has been suggested that after receptor binding, the toxin undergoes a major conformational change which enables the ␣-helix 5 of domain I to penetrate the membrane (31, 32) . Our results suggest that the amino acid residues F-371 and G-374 of loop 2 directly or indirectly play an important role in holding the CryIAb toxin bound to the receptor during the transition state in M. sexta. Also, the irreversible association may be one of the rate-determining steps in the mechanism of action of ␦-endotoxins.
These present results signify that the membrane binding might be a two-step process (at least in this case): (i) recognition of the target (receptor) molecule and (ii) irreversible association with midgut membrane. Apparently, not all the toxins that initially recognize the receptor(s) go on to the irreversible associated state. This study extends the knowledge of Cry toxin-membrane interaction beyond the analysis of initial binding. In this context, it should be noted that the previous observations (4, 30) in which toxicity was not correlated with binding should be interpreted with caution. Those conclusions were drawn from simple protein blotting and homologous and heterologous competition binding studies which do not distinguish the reversible and irreversible steps. The analysis of the ratio of reversible to irreversible components in those toxins to the corresponding insects would be necessary before making any conclusion on the relationship between toxicity and receptor binding.
The relationship between toxicity and irreversible membrane association is further strengthened by the results of voltage clamping experiments with M. sexta midgut membrane. Our toxicity data and dissociation binding data are consistent with the voltage clamping data. The toxins that have a greater irreversible association with the membrane inhibit the Isc more efficiently than the toxins with reduced membrane association (Fig. 6) . These results suggest that the irreversible binding of the toxins to BBMV could be used to measure the relationship between toxicity and binding.
B. thuringiensis ␦-endotoxin potency requires a number of factors, including solubilization and prompt proteolytic activation of the toxin (12) , recognition of the specific membrane receptors present in the susceptible insects, irreversible association with the membrane, and the ability to create ion channels causing solute leakage leading to membrane disruption. These results open interesting perspectives for further studies on the mode of action of B. thuringiensis ␦-endotoxins. Further analysis of the irreversible association of Cry toxins to different insect (susceptible and resistant) BBMVs will possibly answer the question of whether the relationship between toxicity and irreversible association to the midgut epithelial cells applies as a general rule.
